Displaying 1 - 10 of 590
Access one-on-one personalized support
Updated:
How can we help? If you have a lot of questions right now or you cannot find what you’re looking for, you’ve come to the right place. You can talk to us directly and receive personalized assistance in finding answers to your questions or ways to address your concerns.
Personalized support
Why Participate in Light The Night?
Updated:
Joining Light The Night is an extraordinary opportunity to be part of something bigger than yourself.
Who we are
Updated:
We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing…
Living and thriving through a blood cancer experience
Updated:
LLSC is the largest voluntary health agency dedicated to funding blood cancer research, advocating for equitable access to treatment, and offering support
First Connection Peer Support Program
Updated:
Being able to speak to someone who has been through a similar blood cancer experience helps to rebuild the strength and courage for those newly diagnosed.
Personalized support
Immune effector cell-associated neurotoxicity syndrome (ICANS)
Updated:
Immune effector cell-associated neurotoxicity syndrome (ICANS) is a side effect that can happen after some forms of immunotherapy treatment. It may cause you to experience serious neurological symptoms.
Treatment and side effects
Volunteer for a better tomorrow
Updated:
Join us by volunteering whether you have experienced a blood cancer firsthand or you want to help the blood cancer community. You can bring hope for a better tomorrow.
Connect with us
Updated:
If you have a lot of questions right now or you cannot find what you’re looking for, you’ve come to the right place. You can talk to us directly and receive personalized assistance in finding answers to your questions or ways to address your concerns. People who call us know…
Myelofibrosis (MF) therapies: From palliation to disease modification - myeloproliferative neoplasms (MPN) conference 2025
Updated:
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Myeloproliferative neoplasms
Preparing for Treatment with Shae-Lynn
Updated:
After being diagnosed with leukemia at 21 years old, Shae-Lynn Way shares her experience with shifting her mindset while preparing for a second stem cell transplant after her leukemia returned.
Leukemia, Treatment and side effects